Navigation Links
Zebra Technologies Introduces New Soft Infant Wristbands for Improved Safety and Comfort
Date:3/3/2009

New Z-Band(R) Direct and Z-Band QuickClip wristbands enable fast and reliable patient identification at the point of care

VERNON HILLS, Ill., March 3 /PRNewswire-FirstCall/ -- Zebra Technologies (Nasdaq: ZBRA), a global leader in delivering on-demand specialty printing solutions for the healthcare industry, has introduced a new line of soft, easy-to-wear Z-Band Direct and Z-Band QuickClip wristbands for infants to ensure comfort and improve safety.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78107)

Approximately one out of 15 hospitalized children will be the victim of a medication error, according to a 2008 study published in Pediatrics. Bar coding has been shown to substantially reduce dangerous and costly medical errors, including adverse drug events.

"Patient safety for infants - particularly medication safety - is a growing concern at hospitals nationwide," said Craig Swanson, Director of Marketing - Products & Services at Zebra Technologies. "By utilizing bar coded wristbands, healthcare providers can extend safeguards throughout the care process and reduce errors."

Made of a soft nylon material, the premium direct thermal wristbands by Zebra Technologies feature a new adjustable design to ensure an optimal fit for small infant wrists. The bands, which support both linear and two-dimensional bar codes, include a flat surface print area that supports higher first-time scan rates and minimizes any scanning issues that may result from the curvature of an infant's wrist. The wristbands are designed for use with Zebra's desktop printers, including the new HC100 direct thermal cartridge printer.

"Bar coded wristbands are the cornerstone of patient safety be
'/>"/>

SOURCE Zebra Technologies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Microbiotic technology developed for microinjection of zebrafish embryos
2. NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases
3. Transparent zebrafish help researchers track breast cancer
4. Phylonix granted broad European patent for transplanting human cells into zebrafish
5. Zebrafish provide useful screening tool for genes, drugs that protect against hearing loss
6. Zebrafish may help solve ringing in vets ears
7. Secret to Treating Tinnitus in Vets May Be Unlocked in Zebrafish
8. Zebrafish enable scientists to study the migration of neurons that enable sexual maturity
9. Zebra Technologies Introduces HC100(TM) Patient I.D. Wristbanding Solution
10. Zebrafish Journal Publishes Skin Pigmentation Studies That Shed Light on the Evolution of Race
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... survey of Fortune 1000 employers strongly indicates that wellness programs ... benefits. , ... Minneapolis, MN (PRWEB) ... companies reveals that 78 percent of employers have improved employee ... program. In the survey, conducted by Hallmark Insights, ...
(Date:12/16/2009)... Dec. 16 Tyco International Ltd. (NYSE: ... of Michael E. Daniels for election to the ... General Meeting on March 10, 2010. ,, ... Global Technology Services group of International Business Machines ... for IBM,s Global Services business operations consisting of ...
(Date:12/16/2009)... 16 Dale Buchanan, owner of Supreme Ultimate ... a weight loss contest for his students in the new ... are not competing for their own prize or against each ... the Tri County Humane Society in Boca Raton, ... loses between January 4 and February 28, 2010 I will ...
(Date:12/16/2009)... Study finds 6- to 11-month interval lessens complication risks , , ... bundle of joy has had such a profound impact on ... take a breath. A new study suggests that you ... pregnant again, and that more than 11 months could be ... interval between pregnancies was less than six months, the chances ...
(Date:12/16/2009)... received a further 1.6 million Euro in capital funding to ... in order to meet the rapidly growing demand for this promising ... A/S that continue to own each about 50% of the company. ... ... Unisense FertiliTech A/S has received a further 1.6 million Euro ...
Breaking Medicine News(10 mins):Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 2
... that millions of newborn babies, //children and mothers die each ... of better healthcare by governments and donor countries. ... the health situation in several countries has not improved in ... ,According to the WHO African countries accounted for 19 of ...
... Canadian cities reveals that the legal prescription drugs such ... heroin, raising questions about drug control in the country. ... or prescription painkillers are at increasing rate though heroin ... Canada for years. ,Dr. Benedikt Fischer, a ...
... its readiness to increase its health sector cooperation with ... products. ,"We hope to enhance cooperation in the ... and doctors' exchange programmes," Hamad bin Abdullah Al-Manie, the ... ,Al-Manie, who is currently in India, was speaking at ...
... are holiday traditions, but UT Southwestern Medical Center experts warn ... for the 6 million Americans who have diabetes and don’t ... obesity, can be a silent killer because its symptoms aren’t ... disease or other maladies. ,That’s bad news for ...
... A New survey reveals that majority of doctors' fail in ... problems. //Four in five GPs are not able to correctly ... can pose a risk to long-term health. ,The ... taskforce Act Against Allergy and is sponsored by SHS International. ...
... practitioners need better resources and support to care for ... researchers. // ,In an editorial for ... general practice and family health specialists have outlined new ... in which partner violence is occurring. ...
Other Medicine News:Health News:WHO Attributes Death of Millions in Africa to Treatable diseases 2Health News:Prescription Opioids Abused More Than Heroin - A Report Says 2Health News:Holiday Gluttony Can Spell Disaster for Undiagnosed Diabetics 2Health News:Majority Of Doctors Tend To Ignore Milk Allergy Cases In Babies 2Health News:Tackling Violence in Families 2
(Date:12/16/2009)... Dec. 16 Savara, Inc., an inhalation drug ... second tranche in its Series A financing round, exceeding ... ,, Funds raised in the Series A round ... NanoCluster technology. ,, "We now have the runway ... of the NanoCluster technology," said Rob Neville, CEO of ...
(Date:12/16/2009)... Dec. 16 ChemoCentryx, Inc. today announced ... Phase 2 clinical trial of CCX354, an orally-bioavailable, ... the CCR1 chemokine receptor for the treatment of ... highly potent and selective antagonist of CCR1, a ... cells, such as monocytes and macrophages, associated with ...
(Date:12/16/2009)... -- , - ... a Total of Over,640 patients Ahead of ... NV (Euronext Brussels: THR), a biopharmaceutical company,focused ... treatments for eye,disease, vascular disease and cancer, ... of the second Phase III trial evaluating ...
Breaking Medicine Technology:Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 3ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 4ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 5ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 1Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 2Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 3Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 4Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 5Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 6Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 7Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 8Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 9Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 10Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 11Finding a protective mechanism for retinal cells could save sight 14859 1Finding a protective mechanism for retinal cells could save sight 14859 2Bacterial ropes tie down shifting Southwest 10753 1Bacterial ropes tie down shifting Southwest 10753 2
... is an urgent need for more,comprehensive lipid control to ... A new 30-year analysis of the,National Health and ... Association (NLA) indicates that while,Americans are doing a better ... adults with high triglycerides, a blood fat linked to ...
... Data from an investigational,open-label, randomized study assessing ... treating anemia in subjects with Stages 3 ... today at the American Society,of Nephrology 41st ... including the FDA-approved,three-times-per-week (TIW) regimen, plus once-a-week ...
Other Medicine Technology:New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity 2New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 2Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 4Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 6
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i...
... InstaTest IgE test kit is an immunochromatographic ... levels of immunoglobulin E in human serum ... commonly associated with allergic pathologies. It may ... some infections. Rapid detection of IgE using ...
... is an all new, completely re-engineered high performance ... LOWEST CROSSING PROFILE PTCA products available ... profile of only 0.17. Atriums all new HyperLite ... catheter ever!, ,Atriums new "Dura-Blend tip technology is ...
... The Veris physiological monitor offers a ... those specifically designed for pediatric and neonate ... up to 3T. Veris is the first ... needs of pediatric and neonate patient monitoring. ...
Medicine Products: